XML 25 R19.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Stock Option Activity

A summary of the Company’s stock option activity under its Plans is as follows (in thousands, except share, per share data and years):

 

 

 

Number of
Options

 

 

Weighted-
Average
Exercise Price

 

 

Weighted-
Average
Remaining
Contractual
Term (in years)

 

 

Aggregate
Intrinsic Value

 

Outstanding at December 31, 2024

 

 

8,873,071

 

 

$

12.81

 

 

 

7.2

 

 

$

361,595

 

Granted

 

 

1,329,425

 

 

$

52.74

 

 

 

 

 

 

 

Exercised

 

 

(103,884

)

 

$

8.68

 

 

 

 

 

 

 

Forfeited or cancelled

 

 

(103,548

)

 

$

42.87

 

 

 

 

 

 

 

Outstanding at March 31, 2025

 

 

9,995,064

 

 

$

17.85

 

 

 

7.3

 

 

$

131,168

 

Vested and expected to vest at March 31, 2025

 

 

9,995,064

 

 

$

17.85

 

 

 

7.3

 

 

$

131,168

 

Exercisable at March 31, 2025

 

 

6,233,188

 

 

$

11.61

 

 

 

6.4

 

 

$

98,765

 

Summary of Fair Value of Stock Option Grants

The assumptions used in the Black-Scholes option pricing model to determine the fair value of stock option grants under the Plans were as follows:

 

 

 

Three Months Ended March 31,

 

 

2025

 

2024

Risk-free interest rate

 

4.0% – 4.4%

 

3.8% – 4.2%

Expected volatility

 

103% – 104%

 

83% – 86%

Expected term (in years)

 

6.1 – 10.0

 

6.1

Expected dividend yield

 

 

Summary of Stock-Based Compensation Expense

Stock-based compensation expense has been reported in the condensed statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Research and development

 

$

5,199

 

 

$

2,184

 

General and administrative

 

 

5,503

 

 

 

3,441

 

Total

 

$

10,702

 

 

$

5,625

 

 

Summary of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consists of the following:

 

 

 

March 31,
2025

 

 

December 31,
2024

 

Common stock options outstanding

 

 

9,995,064

 

 

 

8,873,071

 

RSUs outstanding

 

 

603,132

 

 

 

341,847

 

Shares available for issuance under the Plans

 

 

6,597,728

 

 

 

5,131,660

 

Shares available for issuance under the ESPP

 

 

2,096,962

 

 

 

1,506,316

 

Pre-funded common stock warrants outstanding

 

 

2,676,804

 

 

 

2,676,804

 

Total

 

 

21,969,690

 

 

 

18,529,698

 

Two Thousand Twenty One Equity Incentive Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Restricted Stock Unit ("RSU") Activity

A summary of the Company’s restricted stock unit (“RSU”) activity under the 2021 Plan is as follows:

 

 

 

Number of
Restricted Stock Units

 

 

Weighted-
Average Grant Date Fair Value per Share

 

Outstanding at December 31, 2024

 

 

341,847

 

 

$

59.09

 

Granted

 

 

301,080

 

 

$

51.95

 

Vested

 

 

 

 

$

 

Forfeited or cancelled

 

 

(39,795

)

 

$

48.72

 

Outstanding at March 31, 2025

 

 

603,132

 

 

$

56.21